Inventor · disambiguated record
Jerry L. Bryant, Jr.
Also filed as: BRYANT JERRY · BRYANT JERRY L · BRYANT JR JERRY L
7 granted patents·8 pending applications·30 citations·filing 2003–2022
80Inventor score
Top patents by PatentIndex Score
15 records- 0186US9632069B2Integrated systems and methods of evaluating cannabis and cannabinoid products for public safety, quality control and quality assurance purposesJACKSON JR ELIAS BERNARD·Filed 2014·Granted Apr 25, 2017·18 cites·25 claims
- 0283US10222361B2Integrated systems and methods of evaluating cannabis and cannabinoid products for public safety, quality control and quality assurance purposesVYRIPHARM LLC·Filed 2017·Granted Mar 5, 2019·5 cites·21 claims
- 0375US11378564B2Systems and methods for integrated and comprehensive management of cannabis productsVYRIPHARM ENTPR LLC·Filed 2019·Granted Jul 5, 2022·2 cites·14 claims
- 0472US9050378B2N2S2 chelate-targeting ligand conjugatesYANG DAVID J·Filed 2003·Granted Jun 9, 2015·4 cites·22 claims
- 0562US7611693B2Mechanism-based targeted pancreatic beta cell imaging and therapyUNIV TEXAS·Filed 2004·Granted Nov 3, 2009·1 cites·10 claims
- 0658US11554184B2Synthetic cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseasesVYRIPHARM ENTPR INC·Filed 2022·Granted Jan 17, 2023·0 cites·6 claims
- 0758US2010278731A1Mechanism-Based Targeted Pancreatic Beta Cell Imaging and TherapyYANG DAVID J·Filed 2009·Application pending·0 cites
- 0854US12510524B2Compositions containing cannabinoid analog conjugates and methods of useVYRIPHARM ENTPR LLC·Filed 2020·Granted Dec 30, 2025·0 cites·6 claims
- 0952US2004166058A1Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imagingUNIV TEXAS·Filed 2003·Application pending·0 cites
- 1050US2022370650A1Formulations and kits for the diagnostic evaluation of infectious diseases and methods thereofVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
- 1150US2022305148A1Natural cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseasesVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
- 1250US2022305145A1Compositions and methods for diagnosing viral infections including covid-19 and for infection severity monitoring as well as targeted detection of cytokine stormVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
- 1343US2017281806A1Chelator-targeting ligand conjugates for cardiovascular imagingCELL>POINT LLC·Filed 2017·Application pending·0 cites
- 1441US2022305146A1Radiopharmaceutical compositions and methods for infectious disease diagnosis and therapyVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
- 1531US2011085969A1Chelator-targeting ligand conjugates for cardiovascular imagingROLLO F DAVID·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →